日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of ECOG performance status 2 participants on outcomes of pivotal cancer clinical trials: a meta-analysis and meta-regression

ECOG 体能状态 2 级参与者对关键癌症临床试验结果的影响:一项荟萃分析和荟萃回归分析

Iannantuono, G M; Giovagnoli, T; Mastrantoni, L; Gyawali, B; Floudas, C S; Sganga, S; Giannarelli, D; Filetti, M; Spinazzola, A; Lo Bianco, F; Giudice, E; Vitale, A; Gulley, J L; Navarra, P; Bria, E; Daniele, G

Deciphering brain metastasis in epithelial ovarian cancer: multimodal analysis and potential biomarkers

解读上皮性卵巢癌脑转移:多模态分析和潜在生物标志物

Trozzi, R; Salvi, M; Karimi, M; Minucci, A; Raspaglio, G; De Donato, M; Buttarelli, M; Piermattei, A; Vaccaro, L; Grimaldi, A; De Santis, R; Massa, M; Sillano, F; Giacò, L; Mastrantoni, L; Iacobelli, V; Camarda, F; Cesana, M; Duranti, S; Sassu, M C; Mattogno, P; Fagotti, A; Marchetti, C; Scambia, G; Nero, C; Cacchiarelli, D

Predicting progression-free survival in hormone-receptor positive (HR+/HER2-) metastatic breast cancer (MBC) treated with CDK4/6 inhibitors: A machine learning approach

预测接受 CDK4/6 抑制剂治疗的激素受体阳性 (HR+/HER2-) 转移性乳腺癌 (MBC) 患者的无进展生存期:一种机器学习方法

Pannunzio, Sergio; Mastrantoni, Luca; Maliziola, Noemi; Pontolillo, Letizia; Garufi, Giovanna; Di Monte, Elena; Emiliani, Alessandra; Sgambato, Margherita; Cardillo, Anna; Palazzo, Antonella; Orlandi, Armando; Tortora, Giampaolo; Bria, Emilio

Concordance Analysis of Microsatellite Instability via NGS and Mismatch Repair Deficiency via IHC in Endometrial and Colorectal Cancer

利用NGS检测微卫星不稳定性,并利用IHC检测子宫内膜癌和结直肠癌错配修复缺陷,进行一致性分析

Nero, Camilla; Salvatore, Lisa; Duranti, Simona; Anderson, Gloria; Mastrantoni, Luca; Karimi, Mina; Mantini, Giulia; Minucci, Angelo; Maneri, Giulia; Giacò, Luciano; Santoro, Angela; Panfili, Arianna; Piermattei, Alessia; Marino, Ilenia; Caira, Giulia; Calegari, Maria Alessandra; Trovato, Giovanni; Iacobelli, Valentina; Salutari, Vanda; Normanno, Nicola; Fanfani, Francesco; Scambia, Giovanni; Tortora, Giampaolo

Next Frontier in HER2+/HR+ Breast Cancer: Leveraging Cell Cycle Control with CDK4/6 Inhibitors

HER2+/HR+乳腺癌的下一个前沿领域:利用CDK4/6抑制剂调控细胞周期

Poli, Ilaria; Oliva, Gaia Rachele; Mongelli, Ginevra; Rotondi, Angelachiara; Frescura, Valentina; Arcuri, Giorgia; Garufi, Giovanna; Pontolillo, Letizia; Mastrantoni, Luca; Di Monte, Elena; Maliziola, Noemi; Fucile, Maria Antonia; Salvatori, Francesca; Mondello, Rita; Palazzo, Antonella; Fabi, Alessandra; Bria, Emilio; Tortora, Giampaolo; Orlandi, Armando

Development and Validation of Multivariable Machine-Learning Models for the Prediction of Multisystemic Inflammatory Syndrome Outcomes in Latin American Children

开发和验证用于预测拉丁美洲儿童多系统炎症综合征预后的多变量机器学习模型

Buonsenso, Danilo; Mastrantoni, Luca; Ulloa-Gutierrez, Rolando; García-Silva, Jimena; Ivankovich-Escoto, Gabriela; Yamazaki-Nakashimada, Marco A; Faugier-Fuentes, Enrique; Del Águila, Olguita; Camacho-Moreno, German; Estripeaut, Dora; Gutiérrez-Tobar, Iván F; Tremoulet, Adriana H

Granulocyte colony-stimulating factor acts through calcium-permeable AMPA receptors to potentiate cocaine reward.

粒细胞集落刺激因子通过钙离子通透性AMPA受体发挥作用,增强可卡因的奖赏效应。

Hofford Rebecca S, Wilson Rashaun, McArdle Colin, Euston Tanner, Sens Jonathon P, Mastrantoni Abigail, McCabe Taylor, Meckel Katherine R, Wang Weiwei, Lucerne Kelsey E, Osman Aya, Raab-Graham Kimberly F, Lam TuKiet T, Kiraly Drew D

Development and Validation of Quantile Regression Forests for Prediction of Reference Quantiles in Handgrip and Chair-Stand Test

开发和验证分位数回归森林模型,用于预测握力和椅子站立测试中的参考分位数

Giordano, Giulia; Mastrantoni, Luca; Landi, Francesco

Actionable mutations in early-stage ovarian cancer according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT): a descriptive analysis on a large prospective cohort

根据ESMO分子靶点临床可操作性量表(ESCAT)评估早期卵巢癌中可操作的突变:一项基于大型前瞻性队列的描述性分析

Camarda, F; Mastrantoni, L; Parrillo, C; Minucci, A; Persiani, F; Giannarelli, D; Pasciuto, T; Giacomini, F; De Paolis, E; Manfredelli, M; Marchetti, C; Zannoni, G F; Fagotti, A; Scambia, G; Nero, C

Network analysis of NRG1 variants of uncertain significance (VUSes) in advanced non-small-cell lung cancer and their prognostic role in EGFR-mutant patients treated with first-line osimertinib

对晚期非小细胞肺癌中意义未明的NRG1变异体(VUS)进行网络分析,并探讨其在接受一线奥希替尼治疗的EGFR突变患者中的预后作用

Vita, E; Scala, A; Vitale, A; Mastrantoni, L; Evangelista, J; D'Auria, F; Stefani, A; Monaca, F; Russo, J; Horn, G; Troisi, P; Cosmai, A; Polidori, S; Di Salvatore, M; De Paolis, E; Minucci, A; Nero, C; Trisolini, R; Cancellieri, A; Scambia, G; Tortora, G; Bria, E